… The aims of this review are to: provide an overview of the key early immune checkpoint
inhibitor … a detailed exploration of the status of immune checkpoint inhibitors in breast cancer. …

… checkpoints are currently under clinical development. In this review we summarize
current research in breast cancer… search terms: “checkpoint inhibitor” and “breast cancer” (PubMed …

… directed against other immune checkpoints are currently under … the implementation of
checkpoint inhibition in breast cancer by … immunity in breast cancer with checkpoint …

… In this article, the authors review the current literature on checkpoint inhibitors in TNBC
with a focus on PD-1/PD-L1 antibodies and discuss combination strategies and novel …

… Immune-checkpoint inhibitors (ICIs) represent a major development in cancer therapy. The …
For years breast cancer (BC) has been considered immunologically quiescent compared with …

… for many cancers has dramatically changed with the development of checkpoint inhibitors. …
article will review the literature concerning the use of checkpoint inhibitors in breast cancer. …

… In this review, we will focus on triple negative breast cancer as immunogenic breast cancer
subtype, and specifically discuss the relevance of tumor mutational burden, the plethora and …

… checkpoint inhibitors have been approved in combination with chemotherapy for PD-L1
positive advanced triple-negative breast cancer (… of checkpoint inhibitors in breast cancer is …

… with immune checkpoint blockade in breast cancer and future … that PARP inhibitors can
upregulate PD-L1 in breast cancer … I study in women's cancers investigating the PD-L1 inhibitor …

… response to PD-1/PD-L1 checkpoint inhibition according to the analyses of more than 10
different solid tumors, which was the same as that for breast cancer in our results. PD-L1 mainly …